Home / Japan / Nxera Pharma Co.,Ltd.
Nxera Pharma Co.,Ltd.
Short position disclosed on September 18, 2026.
0.72% of the capital sold short
1 disclosing fund
65 disclosures on record
Evolution of the disclosed total
0%2%4%6%8%
Aug 14Aug 25Sep 5Sep 16
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| モルガン・スタンレーmufg証券株式会社 | 0.72% | new | September 18, 2026 |
Get the moves on Nxera Pharma Co.,Ltd. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 13, 2026 | Goldman Sachs International | 1.54% | |
| August 12, 2026 | Barclays Capital Securities Ltd | 1.15% | |
| August 12, 2026 | UBS AG | 0.82% | |
| August 10, 2026 | UBS AG | 0.79% | |
| August 7, 2026 | Goldman Sachs International | 1.69% | |
| August 7, 2026 | Citigroup Global Markets Limited | 1.11% | |
| August 7, 2026 | Barclays Capital Securities Ltd | 1.09% | |
| August 7, 2026 | UBS AG | 0.68% | |
| August 6, 2026 | Goldman Sachs International | 1.56% | |
| August 6, 2026 | Barclays Capital Securities Ltd | 1.11% | |
| August 6, 2026 | UBS AG | 0.79% | |
| August 5, 2026 | Goldman Sachs International | 1.60% | |
| August 5, 2026 | Barclays Capital Securities Ltd | 1.09% | |
| August 3, 2026 | Citigroup Global Markets Limited | 1.00% | |
| August 3, 2026 | Barclays Capital Securities Ltd | 0.95% |
Download 65 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- Metaplanet Inc. 12.12% of the capital sold short
- Towa Corporation 10.64% of the capital sold short
- 3-D Matrix,Ltd. 10.34% of the capital sold short
- KLab Inc. 10.28% of the capital sold short
- QD Laser,Inc. 10.26% of the capital sold short
- Jibannet Holdings Co.,Ltd. 9.53% of the capital sold short
- SHIFT Inc. 9.38% of the capital sold short
- ReYuu Japan Inc. 8.91% of the capital sold short
- Renascience Inc. 8.76% of the capital sold short
- Unitika LTD. 8.57% of the capital sold short
- Fixstars Corporation 7.96% of the capital sold short
- Infomart Corporation 7.44% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Nxera Pharma Co.,Ltd., source JPX, data as at September 18, 2026, https://www.quivad.com/action/nxera-pharma-co-ltd?page=2